PET/MR在头颈癌中的应用更新
本文综述了近6年PET/MR在头颈癌中的临床应用进展,指出一体化同时PET/MR已取代序贯PET+MR,多项研究显示其在分期、再分期和放疗计划方面总体与PET/CT表现相当,多参数成像在肿瘤表征和预后方面有优势但需严格准备与验证,目前多数临床研究聚焦FDG用于上呼吸消化道鳞癌,未来需针对特定病理实体和非FDG示踪剂开展研究。
要点
- PET/MR在头颈癌分期、再分期和放疗计划中总体与PET/CT表现相当
- 多参数PET/MR在肿瘤表征和预后方面有优势但需严格准备与验证
- 现有临床PET/MR研究多数为FDG用于上呼吸消化道鳞癌
核心结论
- PET/MR在头颈癌分期、再分期和放疗计划中总体与PET/CT表现相当。
- 多参数PET/MR在头颈恶性肿瘤表征和预后方面似乎有优势,但需严格准备和验证成像模式。
研究设计与样本
- 本文为综述,纳入自上次本刊综述以来6年内PET/MR在头颈癌患者中的应用文献。
主要发现
- 旧有序贯PET+MR设备已基本从临床站点消失,被一体化同时PET/MR扫描仪取代。
- 多数现有临床PET/MR研究覆盖上呼吸消化道广泛部位鳞状细胞癌的FDG成像。
- 未来需要针对特定组织病理肿瘤实体、非上皮恶性肿瘤及非FDG放射性示踪剂成像的专门PET/MR研究。
临床怎么用
- 在学术中心可将PET/MR用于头颈癌分期、再分期和放疗计划,其总体表现与PET/CT相当。
- 利用多参数PET/MR进行肿瘤表征和预后评估时,需确保成像模式的精确准备与验证。
- PET/MR广泛使用受限于设备成本高和设施要求,且多学科头颈癌治疗主要集中在学术中心。
局限性
- PET/MR扫描仪成本仍较高且设施要求高,限制其在大型医院外的广泛使用。
- 现有多数临床研究聚焦FDG用于上呼吸消化道鳞癌,特定病理实体和非FDG示踪剂研究不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In academic centers, PET/MR has taken the road to clinical nuclear medicine in the past 6 years since the last review on its applications in head and neck cancer patients in this journal. Meanwhile, older sequential PET + MR machines have largely vanished from clinical sites, being replaced by integrated simultaneous PET/MR scanners. Evidence from several studies suggests that PET/MR overall performs equally well as PET/CT in the staging and restaging of head and neck cancer and in radiation therapy planning. PET/MR appears to offer advantages in the characterization and prognostication of head and neck malignancies through multiparametric imaging, which demands an exact preparation and validation of imaging modalities, however. The majority of available clinical PET/MR studies today covers FDG imaging of squamous cell carcinoma arising from a broad spectrum of locations in the upper aerodigestive tract. In the future, specific PET/MR studies are desired that address specific histopathological tumor entities, nonepithelial malignancies, such as major salivary gland tumors, squamous cell carcinomas arising in specific locations, and malignancies imaged with non-FDG radiotracers. With the advent of digital PET/CT scanners, PET/MR is expected to partake in future technical developments, such as novel iterative reconstruction techniques and deviceless motion correction for respiration and gross movement in the head and neck region. Owing to the still comparably high costs of PET/MR scanners and facility requirements on the one hand, and the concentration of multidisciplinary head and neck cancer treatment mainly at academic centers on the other hand, a more widespread use of this imaging modality outside major hospitals is currently limited.
引用
- Huellner MW. PET/MR in Head and Neck Cancer - An Update. Semin Nucl Med. 2020. PMID: 33246536. doi:10.1053/j.semnuclmed.2020.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。